Thyroid Gland Anaplastic Carcinoma
Also known as: Anaplastic Thyroid Carcinoma / Thyroid Carcinoma, Anaplastic / Anaplastic thyroid cancer / Anaplastic thyroid carcinoma (disorder)
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB08912 | Dabrafenib | 1 | Recruiting | 1 |
| DB08911 | Trametinib | 1 | Recruiting | 1 |
| DB00062 | Albumin human | 2 | Active Not Recruiting | 1 |
| DB00041 | Aldesleukin | 2 | Active Not Recruiting | 1 |
| DB11595 | Atezolizumab | 2 | Active Not Recruiting | 1 |
| DB00112 | Bevacizumab | 2 | Active Not Recruiting | 1 |
| DB05239 | Cobimetinib | 2 | Active Not Recruiting | 1 |
| DB00531 | Cyclophosphamide | 2 | Active Not Recruiting | 1 |
| DB08912 | Dabrafenib | 2 | Recruiting | 1 |
| DB08912 | Dabrafenib | 2 | Withdrawn | 1 |
| DB01073 | Fludarabine | 2 | Active Not Recruiting | 1 |
| DB06186 | Ipilimumab | 2 | Active Not Recruiting | 1 |
| DB09078 | Lenvatinib | 2 | Terminated | 1 |
| DB17107 | Lifileucel | 2 | Active Not Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
| DB01229 | Paclitaxel | 2 | Active Not Recruiting | 1 |
| DB01229 | Paclitaxel | 2 | Completed | 1 |
| DB06589 | Pazopanib | 2 | Completed | 2 |
| DB09037 | Pembrolizumab | 2 | Recruiting | 1 |
| DB15685 | Selpercatinib | 2 | Recruiting | 1 |
| DB08911 | Trametinib | 2 | Recruiting | 1 |
| DB08911 | Trametinib | 2 | Withdrawn | 1 |
| DB08881 | Vemurafenib | 2 | Active Not Recruiting | 1 |
| DB05239 | Cobimetinib | 2 / 3 | Recruiting | 1 |
| DB08881 | Vemurafenib | 2 / 3 | Recruiting | 1 |